GlassScriptPhysician profile
Hojin Lee
NPI 1063745644
$2,139.42
in general payments reported to CMS, 2019-2025
8 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $263 · 2023: $1,651 · 2024: $48.99 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $949 · Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $949.46 |
| Food and Beverage | $926.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,175.39 | 2023 | Truelok, Truelok System |
| Integra Lifesciences Corporation | $654.60 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $92.29 | 2024-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Medtronic, INC. | $83.97 | 2023 | Cd Horizon Spinal System |
| Pfizer INC. | $57.13 | 2025 | |
| Glaxosmithkline, LLC. | $30.20 | 2024-2025 | Bexsero, Penmenvy |
| Alk-Abello, INC | $29.94 | 2025 | Neffy |
| Cranial Technologies, INC | $15.90 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hojin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.